Multivariate analysis of event-free survival in group B
| . | No. of patients . | Relative risk . | P value . |
|---|---|---|---|
| Serum LDH level | .04 | ||
| ≤ 2N7-150 | 198 | 1 | |
| > 2N7-150 | 162 | 2.3 (1.0-5.2) | |
| Age7-151 | .01 | ||
| < 8 years | 174 | 1 | |
| 8-14 y | 167 | 1.4 (0.6-3.4) | |
| ≥ 15 y | 19 | 6.7 (2.2-20.4) | |
| Response to COP7-151 | .006 | ||
| > 80% | 128 | 1 | |
| 20%-79% | 188 | 2.3 (0.76-7.0) | |
| < 20% | 16 | 12.3 (3.2-47.1) | |
| Not evaluated | 28 | 3.2 (0.71-14.8) |
| . | No. of patients . | Relative risk . | P value . |
|---|---|---|---|
| Serum LDH level | .04 | ||
| ≤ 2N7-150 | 198 | 1 | |
| > 2N7-150 | 162 | 2.3 (1.0-5.2) | |
| Age7-151 | .01 | ||
| < 8 years | 174 | 1 | |
| 8-14 y | 167 | 1.4 (0.6-3.4) | |
| ≥ 15 y | 19 | 6.7 (2.2-20.4) | |
| Response to COP7-151 | .006 | ||
| > 80% | 128 | 1 | |
| 20%-79% | 188 | 2.3 (0.76-7.0) | |
| < 20% | 16 | 12.3 (3.2-47.1) | |
| Not evaluated | 28 | 3.2 (0.71-14.8) |